Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 47Observational 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 4

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 405Surgical Procedures, Operative 151Interviews as Topic 131Radiotherapy 130Observation 122Drug Therapy 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 58Watchful Waiting 51Immunotherapy 51Bevacizumab 49Positron Emission Tomography Computed Tomography 46Ultrasonography 44Liquid Biopsy 41Hematologic Tests 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Observational × Ramucirumab × Clear all
NCT06490055 2025-07-18

Predicting the Efficacy in Advanced Gastric Cancer.

City of Hope Medical Center

Completed
162 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06490159 2025-07-11

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

City of Hope Medical Center

Recruiting
150 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06666582 2024-10-30

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

Hellenic Cooperative Oncology Group

Completed
185 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04915807 2021-06-07

Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

Hallym University Medical Center

Unknown
222 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡